LEQEMBI
Live / Registered — Registered (as of 11 Apr 2023)
What this means for you
Registered since 11 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97151804
- Registration number
- 7027708
- Mark type
- Stylized text
- Filed
- 01 Dec 2021
- Published for opposition
- 24 May 2022
- Registered
- 11 Apr 2023
- Attorney of record
- Caroline H. Mead
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related disorders, cognitive impairment and dementia
Owner
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
Prosecution history
- 11 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Mar 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Mar 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Feb 2023 — USE AMENDMENT FILED
- 06 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Feb 2023 — TEAS STATEMENT OF USE RECEIVED
- 10 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2022 — SOU EXTENSION 1 GRANTED
- 08 Sept 2022 — SOU EXTENSION 1 FILED
- 08 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 19 Jul 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 May 2022 — PUBLISHED FOR OPPOSITION